This HFD-associated dysregulation of adiponectin-AMPK signaling has been proposed to contribute to the impairment of insulin sensitivity, through an alteration in fatty acid metabolism that increases lipid accumulation in skeletal muscle which, ultimately, leads to the development of insulin resistance [42-44]. Here, ADIPOQ is linked to Insulin resistance.